Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Health claims meeting

This article was originally published in The Tan Sheet

Executive Summary

An FDA public meeting to assess consumer perceptions of health claims will be held Nov. 17 at the Center for Food Safety & Applied Nutrition Harvey Wiley Auditorium from 9 a.m. to 4:30 p.m., the agency announces in a Federal Register notice Oct. 19. The agency will present findings from research assessing consumer reactions to health claims and "address the implications of these studies for future research" evaluating the effect of health claims on consumer behavior. Those who wish to make presentations must register by Nov. 10. Comments also are being collected through Jan. 17. An FDA study on consumer reactions to health claims was recently released (1"The Tan Sheet" Oct. 10, 2005, p. 7)...

You may also be interested in...

Qualified Claims Language And Grading Confuses Consumers – FDA Study

"Report card grade disclaimers" used to distinguish the amount of scientific evidence backing a health claim may cause consumers to be more skeptical of the science behind unqualified health claims compared to qualified claims, according an FDA survey

Sales Already Growing As Vascepa Secures Cardio Approval

Company forecasts 2020 sales as high as $700m after regulator grants broad label.

Another EU MDR Notified Body In The Netherlands

Last week, the Commission  revealed that three more notified bodies had been designated; but their listings had not been made official. Now we learn that one of the three is in the Netherlands as the first listing takes place.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts